Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)
Hong Kong · Delayed Price · Currency is HKD 4.910
+0.100 (2.08%)
At close: Mar 27, 2026
8.87% (1Y)
| Market Cap | 16.80B +4.5% |
| Revenue (ttm) | 5.88B -1.0% |
| Net Income | 459.25M |
| EPS | 0.31 |
| Shares Out | n/a |
| PE Ratio | 36.57 |
| Forward PE | n/a |
| Dividend | 0.27 (5.56%) |
| Ex-Dividend Date | May 26, 2025 |
| Volume | 513,000 |
| Average Volume | 780,750 |
| Open | 4.940 |
| Previous Close | 4.810 |
| Day's Range | 4.790 - 4.970 |
| 52-Week Range | 3.930 - 7.260 |
| Beta | 0.45 |
| RSI | 37.66 |
| Earnings Date | Mar 30, 2026 |